Archive - January 2018
Study Shows Opioid Prescriptions Come From Doctor Offices, Not Emergency Rooms
MSD’s interim Keytruda combo data spooks Roche and BMS
FDA report reaffirms safety profile and effectiveness of Bayer’s Xarelto® in routine clinical practice
Boehringer’s Gilotrif approved in US for lung cancer with non-resistant EGFRs
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal
Novartis debuts new data showing Cosentyx’s superiority over Janssen’s Stelara in psoriasis
Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia
